Your browser doesn't support javascript.
loading
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
Goldman, Jonathan W; Mazieres, Julien; Barlesi, Fabrice; Dragnev, Konstantin H; Koczywas, Marianna; Göskel, Tuncay; Cortot, Alexis B; Girard, Nicolas; Wesseler, Claas; Bischoff, Helge; Nadal, Ernest; Park, Keunchil; Lu, Shun; Taus, Alvaro; Cobo, Manuel; Estrem, Shawn T; Wijayawardana, Sameera R; Turner, Kellie; Oakley, Gerard Joseph; Hurt, Karla C; Chiang, Alan Y; Hossain, Anwar M; John, William J; Paz-Ares, Luis.
Afiliación
  • Goldman JW; Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
  • Mazieres J; Thoracic Oncology Department, Toulouse University Hospital, Paul Sabatier University, Toulouse, France.
  • Barlesi F; Multidisciplinary Oncology and Innovative Therapies Department, Aix-Marseille University, INSERM, CNRS, CRCM, Assistance Publque Hôspitaux de Marseille (AP-HM), Marseille, France.
  • Dragnev KH; Department of Medicine, Norris Cotton Cancer Center, Dartmouth-Hitchcock, Lebanon, NH, United States.
  • Koczywas M; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, United States.
  • Göskel T; Department of Internal Medical Sciences, Ege University, (Bornova), Izmir, Turkey.
  • Cortot AB; Thoracic Oncology Department, University of Lille, CHU Lille, Lille, France.
  • Girard N; Respiratory Medicine Department, Hospices Civils de Lyon, University of Lyon, Lyon, France.
  • Wesseler C; Department of Thoracic Oncology, Asklepios Klinikum Harburg, Hamburg, Germany.
  • Bischoff H; Department of Thoracic Oncology, Thoraxklinik-Heidelberg, Heidelberg, Germany.
  • Nadal E; Department of Medical Oncology, Catalan Institute of Oncology, (L'Hospitalet), Barcelona, Spain.
  • Park K; Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea.
  • Lu S; Lung Tumor Medical (Cancer) Center, Shanghai Chest Hospital, Shanghai (Jiao Tong University), Shanghai, China.
  • Taus A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.
  • Cobo M; Medical Oncology Department, Hospital Regional Universitario Málaga, IBIMA, Málaga, Spain.
  • Estrem ST; Eli Lilly and Company, Indianapolis, IN, United States.
  • Wijayawardana SR; Eli Lilly and Company, Indianapolis, IN, United States.
  • Turner K; Eli Lilly and Company, Indianapolis, IN, United States.
  • Oakley GJ; Eli Lilly and Company, Indianapolis, IN, United States.
  • Hurt KC; Eli Lilly and Company, Indianapolis, IN, United States.
  • Chiang AY; Eli Lilly and Company, Indianapolis, IN, United States.
  • Hossain AM; Eli Lilly and Company, Indianapolis, IN, United States.
  • John WJ; Eli Lilly and Company, Indianapolis, IN, United States.
  • Paz-Ares L; Department of Medicine, Hospital Universitario 12 de Octubre, CNIO and Universidad Complutense, Madrid, Spain.
Front Oncol ; 10: 578756, 2020.
Article en En | MEDLINE | ID: mdl-33194700
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza